Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Aug 2;20(1):110.
doi: 10.1186/s12958-022-00982-7.

The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial

Mahsima Jaripur  1 , Hatav Ghasemi-Tehrani  2 , Gholamreza Askari  1 , Mahsa Gholizadeh-Moghaddam  1 , Cain C T Clark  3 , Mohammad Hossein Rouhani  4
Affiliations
Randomized Controlled Trial

The effects of magnesium supplementation on abnormal uterine bleeding, alopecia, quality of life, and acne in women with polycystic ovary syndrome: a randomized clinical trial

Mahsima Jaripur et al. Reprod Biol Endocrinol. .

Abstract

Background: Abnormal uterine bleeding (AUB), alopecia, low quality of life, and acne are considered as complications of polycystic ovary syndrome (PCOS). We hypothesized that magnesium supplementation would yield beneficial effects on PCOS related complications.

Objective: To examine the effects of magnesium supplementation on AUB, alopecia, quality of life, and acne.

Methods: In this parallel randomized clinical trial, we randomly assigned 64 women with PCOS to the magnesium group (n = 32) or placebo group (n = 32) for 10 weeks. AUB, alopecia, quality of life, and acne were assessed by the International Federation of Gynecology and Obstetrics criterion, the Sinclair Scale, the Health Survey Quality of Life Questionnaire, and the Global Acne Grading System, respectively. This randomized clinical trial was registered at IRCT.ir (IRCT20130903014551N9).

Results: Magnesium supplementation significantly improved the components of quality of life including physical functioning (p = 0.011), role limitations due to physical health (p = 0.012), role limitations due to emotional problems (p < 0.001), energy/fatigue (p = 0.005), emotional wellbeing (p < 0.001), social functioning (p = 0.002), general health (p = 0.013), and total quality of life (p < 0.001), compared with placebo. No significant effect was observed on acne, alopecia, and AUB.

Conclusion: Magnesium supplementation in women with PCOS had a significant positive effect on improving total quality of life.

Trial registration: This randomized clinical trial was registered at IRCT.ir on 2020-10-18 (Registration Code: IRCT20130903014551N9 ).

Keywords: Abnormal uterine bleeding; Acne; Alopecia; Magnesium; Polycystic ovary syndrome; Quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
CONSORT study flow diagram
See this image and copyright information in PMC

References

    1. Dunaif A. Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabes mellitus. Am J Med. 1995;98(1 SUPPL.1):33S–39S. doi: 10.1016/S0002-9343(99)80057-6. - DOI - PubMed
    1. Okoroh EM, Hooper WC, Atrash HK, Yusuf HR, Boulet SL. Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003–2008. Am J Obstet Gynecol. 2012;207(4):299.e1–299.e7. doi: 10.1016/j.ajog.2012.07.023. - DOI - PubMed
    1. Livadas S, Diamanti-Kandarakis E. Polycystic ovary syndrome: Definitions, phenotypes and diagnostic approach. In: Polycystic Ovary Syndrome: Novel Insights into Causes and Therapy. Front Horm Res. 2013;40:1–21. doi: 10.1159/000341673. - DOI - PubMed
    1. Goldzieher JW, Green JA. The polycystic ovary. I. Clinical and histologic features. J Clin Endocrinol Metab. 1962;22:325–38. 10.1210/jcem-22-3-325. - PubMed
    1. Cela E, Robertson C, Rush K, Kousta E, White DM, Wilson H, et al. Prevalence of polycystic ovaries in women with androgenic alopecia. Eur J Endocrinol. 2003;149(5):439–442. doi: 10.1530/eje.0.1490439. - DOI - PubMed

Publication types